1. Medtech Insight
  2. >>Policy & Regulation

Reimbursement For Shockwave’s IVL Device May Pose Quandary For CMS

 
• By Hannah Daniel

A temporary reimbursement boost for Shockwave’s C2 coronary intravascular lithotripsy (IVL) is coming to an end. John Leppard, Senior Healthcare Analyst & VP at Washington Analysis breaks down what that means for CMS. 

• Source: Shutterstock

Setting an appropriate reimbursement level for the Shockwave Medical, Inc. C2 coronary intravascular lithotripsy (IVL) device could pose a challenge for The US Center for Medicare and Medicaid, one reimbursement expert says.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Medtech Insight

Execs On The Move: 14-18 April 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

AAOS 2025 Orthopedic Roundup: J&J Velys UKA, Stryker Mako 4, Materialise, Canary Medical

 
• By Marion Webb

At AAOS, orthopedics players showcased their latest robotic-assisted platforms, power tools, 3D printed technologies and software offerings. This article brings you highlights from interviews Medtech Insight conducted on site with representatives from J&J, Stryker, Materialise and Canary Medical.

South Korea Adds Digital Health Rules To Already Complicated Regulatory Landscape

 
• By Elizabeth Orr

A New South Korean law, the Digital Medical Products Act, enhances regulation for digital health products. Medical devices in the country are categorized both by risk and by similarity to already authorized devices. The approval process may stretch to 515 days for new manufacturers.